Erdene Resource Development Corp (ERD)
Toronto Exchange · Canada · prices in CAD · close of 22 Oct 2026
Key indicators
| Last close | CAD 5.450 |
|---|---|
| 52-week range | 4.540 – 10.200 |
| Return, 1 month / 3 months | −17.5% / +4.0% |
| Return, 1 year / 3 years | −38.9% / +167.2% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 53.6% |
| Worst drawdown (1 year) | -51.6% |
| Average daily value traded | 0.24M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Erdene Resource Development Corp is a mineral exploration and development company based in Canada that works mainly in Mongolia. It focuses on gold and other metals, with its principal project being the Bayan Khundii gold deposit in the southwestern part of the country. The company explores for and develops mineral resources, and it has also held interests in coal and industrial mineral properties. Its activities serve the mining and metals sector through the discovery and development of ore deposits.
On this site Erdene Resource Development Corp appears as a stock on the Toronto Exchange (Canada), code ERD, with prices in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Erdene Resource Development Corp (ERD) trades on the Toronto Exchange in Canada. It last closed at CAD 5.450 on 22 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 688 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 38.9% and over the last three months it rose 4.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 24 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -17.3% | ||
| From 52-week high | -43.7% | ||
| Momentum | 36 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 4.0% | ||
| 6-month return | -17.7% | ||
| 12-month return, skipping the last month | -25.9% | ||
| Stability (higher is calmer) | 27 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 53.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -51.6% | ||
| Liquidity | 35 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.24M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −6.8% |
|---|---|
| 1 month | −17.5% |
| 3 months | +4.0% |
| 6 months | −17.7% |
| 1 year | −38.9% |
| 3 years | +167.2% |
| 5 years | +106.4% |
Signals
| 50-day / 200-day average | 6.280 / 6.588 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.290 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.